WASHINGTON, DC – May 23, 2011 — Volunteer advocates from the American Cancer Society Cancer Action Network (ACS CAN) will join cancer patients, survivors, caregivers, physicians, and researchers from 18 other organizations in Washington, DC, this week to urge lawmakers to support funding for crit
The American Cancer Society Cancer Action Network (ACS CAN), American Diabetes Association and American Heart Association are jointly calling on Congress to oppose the State Flexibility Act, a bill that would reverse current law and allow states to tighten Medicaid eligibility before health benefit exchanges are created in 2014.
The U.S. House of Representatives is considering a bill aimed at defunding grants that are meant to help states to set up health benefit exchanges.
Statement from American Cancer Society Chief Medical Officer Otis W. Brawley
WASHINGTON, D.C. – April 21, 2011 – “Tremendous progress has been made during the past decade to protect workers and patrons from the hazardous effects of secondhand smoke.
WASHINGTON, D.C. – April 15, 2011 – “People with cancer and their families are urging lawmakers to reject the funding cuts in the House budget resolution for fiscal year 2012 that would make it more difficult, and in some cases impossible, for them to access lifesaving care.
Cancer Research Funding Cuts Limited; Prevention Program Cuts Damaging
WASHINGTON, D.C. – April 14, 2011 – The American Cancer Society Cancer Action Network (ACS CAN), together with several organizations representing people living with pain, sent a letter to the U.S.
WASHINGTON, D.C. -- April 13, 2011 -- The U.S. House of Representatives is scheduled to vote today on a proposal to repeal the new Prevention and Public Health Fund, which is making an unprecedented investment in proven prevention programs in communities nationwide.
WASHINGTON – April 6, 2011 – An amendment by Rep. Debbie Wasserman Schultz (D-FL) to the FY 2012 budget resolution being marked up today in the House Budget Committee would prohibit funding cuts to cancer and other disease research at the National Institutes of Health (NIH).